Regeneron is buying in to Modex Therapeutics’ next-generation antibody platform with a $7 million upfront payment and a total potential deal value exceeding $1 billion. The New York-based biopharma ...
WESTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health (OPK) company, today announced the initiation and recent dosing of the first patient in a Phase 1/2a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback